191 related articles for article (PubMed ID: 14567719)
1. Growth factors and receptors in juvenile nasopharyngeal angiofibroma and nasal polyps: an immunohistochemical study.
Zhang PJ; Weber R; Liang HH; Pasha TL; LiVolsi VA
Arch Pathol Lab Med; 2003 Nov; 127(11):1480-4. PubMed ID: 14567719
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis of steroid hormone receptors in nasopharyngeal angiofibromas.
Gatalica Z
Cancer Lett; 1998 May; 127(1-2):89-93. PubMed ID: 9619862
[TBL] [Abstract][Full Text] [Related]
3. Juvenile nasopharyngeal angiofibroma: an immunohistochemical characterisation of the stromal cell.
Pauli J; Gundelach R; Vanelli-Rees A; Rees G; Campbell C; Dubey S; Perry C
Pathology; 2008 Jun; 40(4):396-400. PubMed ID: 18446631
[TBL] [Abstract][Full Text] [Related]
4. Expression of growth factors, proto-oncogenes, and p53 in nasopharyngeal angiofibromas.
Nagai MA; Butugan O; Logullo A; Brentani MM
Laryngoscope; 1996 Feb; 106(2 Pt 1):190-5. PubMed ID: 8583852
[TBL] [Abstract][Full Text] [Related]
5. Stem cell-related proteins C-KIT, C-MYC and BMI-1 in juvenile nasopharyngeal angiofibroma--do they have a role?
Renkonen S; Häyry V; Heikkilä P; Leivo I; Haglund C; Mäkitie AA; Hagström J
Virchows Arch; 2011 Feb; 458(2):189-95. PubMed ID: 21113618
[TBL] [Abstract][Full Text] [Related]
6. Current molecular profile of juvenile nasopharyngeal angiofibroma: First comprehensive study from India.
Pandey P; Mishra A; Tripathi AM; Verma V; Trivedi R; Singh HP; Kumar S; Patel B; Singh V; Pandey S; Pandey A; Mishra SC
Laryngoscope; 2017 Mar; 127(3):E100-E106. PubMed ID: 27577998
[TBL] [Abstract][Full Text] [Related]
7. [Expression of members of the cadherin-/catenin-protein family in juvenile angiofibromas].
Rippel C; Plinkert PK; Schick B
Laryngorhinootologie; 2003 May; 82(5):353-7. PubMed ID: 12800081
[TBL] [Abstract][Full Text] [Related]
8. Frequent beta-catenin mutations in juvenile nasopharyngeal angiofibromas.
Abraham SC; Montgomery EA; Giardiello FM; Wu TT
Am J Pathol; 2001 Mar; 158(3):1073-8. PubMed ID: 11238055
[TBL] [Abstract][Full Text] [Related]
9. Immunolocalization of activated transforming growth factor beta1 in juvenile nasopharyngeal angiofibroma.
Dillard DG; Cohen C; Muller S; Del Gaudio J; Reichman O; Parrish B; Rackley D; Gal AA
Arch Otolaryngol Head Neck Surg; 2000 Jun; 126(6):723-5. PubMed ID: 10864108
[TBL] [Abstract][Full Text] [Related]
10. Hormonal receptors and vascular endothelial growth factor in juvenile nasopharyngeal angiofibroma: immunohistochemical and tissue microarray analysis.
Liu Z; Wang J; Wang H; Wang D; Hu L; Liu Q; Sun X
Acta Otolaryngol; 2015 Jan; 135(1):51-7. PubMed ID: 25384380
[TBL] [Abstract][Full Text] [Related]
11. Laminin expression in juvenile angiofibroma indicates vessel's early developmental stage.
Starlinger V; Wendler O; Gramann M; Schick B
Acta Otolaryngol; 2007 Dec; 127(12):1310-5. PubMed ID: 17851944
[TBL] [Abstract][Full Text] [Related]
12. Expression of androgen receptors in nasopharyngeal angiofibroma: an immunohistochemical study of 24 cases.
Hwang HC; Mills SE; Patterson K; Gown AM
Mod Pathol; 1998 Nov; 11(11):1122-6. PubMed ID: 9831211
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus and human herpes virus-8 are not associated with juvenile nasopharyngeal angiofibroma.
Carlos R; Thompson LD; Netto AC; Pimenta LG; Correia-Silva Jde F; Gomes CC; Gomez RS
Head Neck Pathol; 2008 Sep; 2(3):145-9. PubMed ID: 20614308
[TBL] [Abstract][Full Text] [Related]
14. Wnt pathway, angiogenetic and hormonal markers in sporadic and familial adenomatous polyposis-associated juvenile nasopharyngeal angiofibromas (JNA).
Ponti G; Losi L; Pellacani G; Rossi GB; Presutti L; Mattioli F; Villari D; Wannesson L; Alicandri Ciufelli M; Izzo P; De Rosa M; Marone P; Seidenari S
Appl Immunohistochem Mol Morphol; 2008 Mar; 16(2):173-8. PubMed ID: 18227724
[TBL] [Abstract][Full Text] [Related]
15. Endoscopic surgery for juvenile nasopharyngeal angiofibroma: where are the limits?
Douglas R; Wormald PJ
Curr Opin Otolaryngol Head Neck Surg; 2006 Feb; 14(1):1-5. PubMed ID: 16467630
[TBL] [Abstract][Full Text] [Related]
16. Perioperative management of pediatric patients undergoing juvenile angiofibroma resection. A case series and educational review highlighting patient blood management.
Longacre MM; Seshadri SC; Adil E; Baird LC; Goobie SM
Paediatr Anaesth; 2023 Jul; 33(7):510-519. PubMed ID: 36869694
[TBL] [Abstract][Full Text] [Related]
17. Systems-level analysis of clinically different phenotypes of juvenile nasopharyngeal angiofibromas.
Renkonen S; Kankainen M; Hagström J; Haglund C; Monni O; Mäkitie AA
Laryngoscope; 2012 Dec; 122(12):2728-35. PubMed ID: 22965421
[TBL] [Abstract][Full Text] [Related]
18. Proliferation, angiogenesis and hormonal markers in juvenile nasopharyngeal angiofibroma.
Saylam G; Yücel OT; Sungur A; Onerci M
Int J Pediatr Otorhinolaryngol; 2006 Feb; 70(2):227-34. PubMed ID: 16023739
[TBL] [Abstract][Full Text] [Related]
19. Steroid hormone receptor expression in nasopharyngeal angiofibromas. Consistent expression of estrogen receptor beta.
Montag AG; Tretiakova M; Richardson M
Am J Clin Pathol; 2006 Jun; 125(6):832-7. PubMed ID: 16690481
[TBL] [Abstract][Full Text] [Related]
20. Clinical correlation of molecular (VEGF, FGF, PDGF, c-Myc, c-Kit, Ras, p53) expression in juvenile nasopharyngeal angiofibroma.
Mishra A; Mishra SC; Tripathi AM; Pandey A
Eur Arch Otorhinolaryngol; 2018 Nov; 275(11):2719-2726. PubMed ID: 30171340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
